These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 3523576

  • 1. A review of controlled studies of adinazolam mesylate in patients with major depressive disorder.
    Feighner JP.
    Psychopharmacol Bull; 1986; 22(1):186-91. PubMed ID: 3523576
    [No Abstract] [Full Text] [Related]

  • 2. Adinazolam--a new antidepressant: findings of a placebo-controlled, double-blind study in outpatients with major depression.
    Dunner D, Myers J, Khan A, Avery D, Ishiki D, Pyke R.
    J Clin Psychopharmacol; 1987 Jun; 7(3):170-2. PubMed ID: 3298327
    [Abstract] [Full Text] [Related]

  • 3. Adinazolam, diazepam, imipramine, and placebo in major depressive disorder: a controlled study.
    Rickels K, London J, Fox I, Hassman H, Csanalosi I, Weise C.
    Pharmacopsychiatry; 1991 Jul; 24(4):127-31. PubMed ID: 1754608
    [Abstract] [Full Text] [Related]

  • 4. Double-blind comparison of alprazolam and adinazolam for panic and phobic disorders.
    Pyke RE, Greenberg HS.
    J Clin Psychopharmacol; 1989 Feb; 9(1):15-21. PubMed ID: 2651489
    [Abstract] [Full Text] [Related]

  • 5. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD, Kaplan M, Potter L, Bloom L, Rickels K.
    Psychopharmacology (Berl); 1986 Feb; 88(4):484-8. PubMed ID: 3085137
    [Abstract] [Full Text] [Related]

  • 6. Adinazolam mesylate and placebo in depressed outpatients: a 6-week, double-blind comparison.
    Cohn JB, Pyke RE, Wilcox CS.
    J Clin Psychiatry; 1988 Apr; 49(4):142-7. PubMed ID: 3281930
    [Abstract] [Full Text] [Related]

  • 7. Double-blind comparison of alprazolam versus imipramine in the inpatient treatment of major depressive illness.
    Lenox RH, Shipley JE, Peyser JM, Williams JM, Weaver LA.
    Psychopharmacol Bull; 1984 Apr; 20(1):79-82. PubMed ID: 6144136
    [No Abstract] [Full Text] [Related]

  • 8. Review of placebo-controlled trials with bupropion.
    Zung WW.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [Abstract] [Full Text] [Related]

  • 9. Alprazolam treatment of postcoronary bypass anxiety and depression.
    Freeman AM, Fleece L, Folks DG, Sokol RS, Hall KR, Pacifico AD, McGiffin DC, Kirklin JK, Zorn GL, Karp RB.
    J Clin Psychopharmacol; 1986 Feb; 6(1):39-41. PubMed ID: 2869060
    [Abstract] [Full Text] [Related]

  • 10. Treatment of atypical depression with moclobemide: a sequential double controlled study.
    Schweitzer I, Tiller J, Maguire K, Davies B.
    Int J Clin Pharmacol Res; 1989 Feb; 9(2):111-7. PubMed ID: 2654034
    [Abstract] [Full Text] [Related]

  • 11. Benzodiazepines as antidepressants. A triazolobenzodiazepine used to treat depression.
    Feighner JP.
    Mod Probl Pharmacopsychiatry; 1982 Feb; 18():196-212. PubMed ID: 6124883
    [No Abstract] [Full Text] [Related]

  • 12. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS, Fawcett J, Hertzman M, Papp LA, Jones W, Patterson WM, Swinson RP, Weise CC, Maddock RJ, Denahan AQ.
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [Abstract] [Full Text] [Related]

  • 13. A comparative study of bupropion and amitriptyline in depressed outpatients.
    Mendels J, Amin MM, Chouinard G, Cooper AJ, Miles JE, Remick RA, Saxena B, Secunda SK, Singh AN.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):118-20. PubMed ID: 6406439
    [Abstract] [Full Text] [Related]

  • 14. Initial clinical evaluation of a new nontricyclic antidepressant: clovoxamine.
    Freeman HL, Wakelin JS, Calanca A, Hole G.
    Adv Biochem Psychopharmacol; 1982 May; 32():69-75. PubMed ID: 7046368
    [No Abstract] [Full Text] [Related]

  • 15. Open trial of buspirone in the treatment of major depressive disorder.
    Schweizer EE, Amsterdam J, Rickels K, Kaplan M, Droba M.
    Psychopharmacol Bull; 1986 May; 22(1):183-5. PubMed ID: 2873610
    [No Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of bupropion in elderly patients: preliminary observations.
    Kane JM, Cole K, Sarantakos S, Howard A, Borenstein M.
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):134-6. PubMed ID: 6406442
    [Abstract] [Full Text] [Related]

  • 17. A new antidepressant agent: amitriptyline-N-oxide.
    Borromei A.
    Adv Biochem Psychopharmacol; 1982 May; 32():43-7. PubMed ID: 7046367
    [No Abstract] [Full Text] [Related]

  • 18. A comparison of adinazolam and desipramine in the treatment of major depression.
    Kennedy SH, de Groot J, Ralevski E, Reed K.
    Int Clin Psychopharmacol; 1991 May; 6(2):65-76. PubMed ID: 1960382
    [Abstract] [Full Text] [Related]

  • 19. SAMe versus placebo: a double blind comparison in major depressive disorders.
    Muscettola G, Galzenati M, Balbi A.
    Adv Biochem Psychopharmacol; 1982 May; 32():151-6. PubMed ID: 7046362
    [No Abstract] [Full Text] [Related]

  • 20. Clinical evaluation of two new antidepressants.
    Gershon S, Georgotas A, Newton R, Bush D.
    Adv Biochem Psychopharmacol; 1982 May; 32():57-68. PubMed ID: 6211943
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.